Researchers at Weill Cornell Medicine have uncovered a key immune pathway that may explain why patients with inflammatory bowel disease…
Browsing: Clinical Updates
A recent analysis explores the growing clinical interest in postbiotics—non-viable microbial products such as short-chain fatty acids (SCFAs), bacterial lysates,…
Guardant Health has received U.S. Food and Drug Administration approval for Guardant360 CDx as a companion diagnostic to identify patients…
A new analysis from the randomized phase 2 Prevent Anal Cancer (PAC) Self-Swab Study, published in JAMA Network Open, suggests…
Most colorectal cancer (CRC) screening tests, including fecal immunochemical (FIT) and multitarget stool DNA tests, require patients to scrape a…
SAGA Diagnostics has launched its ultrasensitive Pathlight™ MRD test for colorectal cancer, extending a platform already in use for early-stage…
A joint task force from the American Society for Gastrointestinal Endoscopy and the American College of Gastroenterology has released an…
What’s new? A research team at Tohoku University (Japan) has developed a high-fidelity endoscopic submucosal dissection (ESD) simulator that closely…
A study of nearly 1,000 patients undergoing EGD for GERD found that four in ten reports lacked adequate documentation of…
After nearly seven decades on the fringes of medicine, fecal microbiota transplantation has finally crossed a regulatory and clinical threshold.…